Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 202

1.

Significance of the inflammation-based prognostic score in recurrent pancreatic cancer.

Nakagawa K, Sho M, Akahori T, Nagai M, Nakamura K, Takagi T, Tanaka T, Nishiofuku H, Ohbayashi C, Kichikawa K, Ikeda N.

Pancreatology. 2019 May 23. pii: S1424-3903(19)30574-5. doi: 10.1016/j.pan.2019.05.461. [Epub ahead of print]

PMID:
31153778
2.

Postoperative Serum C-Reactive Protein Level Predicts Long-Term Outcomes in Stage I Gastric Cancer.

Migita K, Matsumoto S, Wakatsuki K, Kunishige T, Nakade H, Miyao S, Sho M.

J Surg Res. 2019 May 23;242:323-331. doi: 10.1016/j.jss.2019.04.075. [Epub ahead of print]

PMID:
31129241
3.

Laparoscopic versus open liver resection for hepatocellular carcinoma in elderly patients: a multi-centre propensity score-based analysis.

Nomi T, Hirokawa F, Kaibori M, Ueno M, Tanaka S, Hokuto D, Noda T, Nakai T, Ikoma H, Iida H, Komeda K, Ishizaki M, Hayami S, Eguchi H, Matsumoto M, Morimura R, Maehira H, Sho M, Kubo S.

Surg Endosc. 2019 May 15. doi: 10.1007/s00464-019-06812-z. [Epub ahead of print]

PMID:
31093748
4.

Targeting claudin-4 enhances CDDP-chemosensitivity in gastric cancer.

Nishiguchi Y, Fujiwara-Tani R, Sasaki T, Luo Y, Ohmori H, Kishi S, Mori S, Goto K, Yasui W, Sho M, Kuniyasu H.

Oncotarget. 2019 Mar 15;10(22):2189-2202. doi: 10.18632/oncotarget.26758. eCollection 2019 Mar 15.

5.

Long-term survival after adrenal metastasectomy from colorectal cancer: a report of two cases.

Tsujimoto A, Ueda T, Kuge H, Inoue T, Obara S, Nakamoto T, Sasaki Y, Nakamura Y, Koyama F, Sho M.

Surg Case Rep. 2019 Apr 15;5(1):61. doi: 10.1186/s40792-019-0611-z.

6.

Decreased serum carbohydrate antigen 19-9 levels after neoadjuvant therapy predict a better prognosis for patients with pancreatic adenocarcinoma: a multicenter case-control study of 240 patients.

Aoki S, Motoi F, Murakami Y, Sho M, Satoi S, Honda G, Uemura K, Okada KI, Matsumoto I, Nagai M, Yanagimoto H, Kurata M, Fukumoto T, Mizuma M, Yamaue H, Unno M; Multicenter Study Group of Pancreatobiliary Surgery (MSG-PBS).

BMC Cancer. 2019 Mar 21;19(1):252. doi: 10.1186/s12885-019-5460-4.

7.

Anastomotic leakage following retrosternal pull-up.

Matsumoto S, Wakatsuki K, Migita K, Nakade H, Kunishige T, Miyao S, Sho M.

Langenbecks Arch Surg. 2019 May;404(3):335-341. doi: 10.1007/s00423-019-01765-2. Epub 2019 Mar 4.

PMID:
30830313
8.

Phase II Study of the Triple Combination Chemotherapy of SOXIRI (S-1/Oxaliplatin/Irinotecan) in Patients with Unresectable Pancreatic Ductal Adenocarcinoma.

Akahori T, Sho M, Yanagimoto H, Satoi S, Nagai M, Nishiwada S, Nakagawa K, Nakamura K, Yamamoto T, Hirooka S, Yamaki S, Ikeda N.

Oncologist. 2019 Jun;24(6):749-e224. doi: 10.1634/theoncologist.2018-0900. Epub 2019 Jan 24.

PMID:
30679316
9.

Clinical Impact of Neoadjuvant Chemotherapy and Chemoradiotherapy in Borderline Resectable Pancreatic Cancer: Analysis of 884 Patients at Facilities Specializing in Pancreatic Surgery.

Nagakawa Y, Sahara Y, Hosokawa Y, Murakami Y, Yamaue H, Satoi S, Unno M, Isaji S, Endo I, Sho M, Fujii T, Takishita C, Hijikata Y, Suzuki S, Kawachi S, Katsumata K, Ohta T, Nagakawa T, Tsuchida A.

Ann Surg Oncol. 2019 Jun;26(6):1629-1636. doi: 10.1245/s10434-018-07131-8. Epub 2019 Jan 4.

PMID:
30610555
10.

Randomized phase II/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02/JSAP05).

Motoi F, Kosuge T, Ueno H, Yamaue H, Satoi S, Sho M, Honda G, Matsumoto I, Wada K, Furuse J, Matsuyama Y, Unno M; Study Group of Preoperative Therapy for Pancreatic Cancer (Prep) and Japanese Study Group of Adjuvant Therapy for Pancreatic cancer (JSAP).

Jpn J Clin Oncol. 2019 Feb 1;49(2):190-194. doi: 10.1093/jjco/hyy190.

PMID:
30608598
11.

Prognostic value of the fibrinogen-to-platelet ratio as an inflammatory and coagulative index in patients with gastric cancer.

Wakatsuki K, Matsumoto S, Migita K, Kunishige T, Nakade H, Miyao S, Sho M.

Surg Today. 2019 Apr;49(4):334-342. doi: 10.1007/s00595-018-1734-8. Epub 2018 Nov 8.

PMID:
30411155
12.

MAPLE-PD trial (Mesenteric Approach vs. Conventional Approach for Pancreatic Cancer during Pancreaticoduodenectomy): study protocol for a multicenter randomized controlled trial of 354 patients with pancreatic ductal adenocarcinoma.

Hirono S, Kawai M, Okada KI, Fujii T, Sho M, Satoi S, Amano R, Eguchi H, Mataki Y, Nakamura M, Matsumoto I, Baba H, Tani M, Kawabata Y, Nagakawa Y, Yamada S, Murakami Y, Shimokawa T, Yamaue H.

Trials. 2018 Nov 8;19(1):613. doi: 10.1186/s13063-018-3002-z.

13.

Liver Regeneration After Major Liver Resection for Hepatocellular Carcinoma in the Elderly.

Yasuda S, Nomi T, Hokuto D, Yoshikawa T, Matsuo Y, Sho M.

J Invest Surg. 2018 Nov 2:1-7. doi: 10.1080/08941939.2018.1517839. [Epub ahead of print]

PMID:
30388925
14.

Transition of serum cytokines following pancreaticoduodenectomy: A subsidiary study of JAPAN-PD.

Maeda H, Okada KI, Fujii T, Oba MS, Kawai M, Hirono S, Kodera Y, Sho M, Akahori T, Shimizu Y, Ambo Y, Kondo N, Murakami Y, Ohuchida J, Eguchi H, Nagano H, Sakamoto J, Yamaue H.

Oncol Lett. 2018 Nov;16(5):6847-6853. doi: 10.3892/ol.2018.9422. Epub 2018 Sep 7.

15.

A Comparison Between Plastic and Metallic Biliary Stent Placement in Patients Receiving Preoperative Neoadjuvant Chemoradiotherapy for Resectable Pancreatic Cancer.

Nakamura K, Sho M, Akahori T, Nagai M, Nishiwada S, Nakagawa K, Tanaka T, Kichikawa K, Tamamoto T, Hasegawa M, Mitoro A, Yoshiji H, Ikeda N.

World J Surg. 2019 Feb;43(2):642-648. doi: 10.1007/s00268-018-4820-6.

PMID:
30298284
16.

Sustained Elevation of Postoperative Serum Level of Carbohydrate Antigen 19-9 is High-Risk Stigmata for Primary Hepatic Recurrence in Patients with Curatively Resected Pancreatic Adenocarcinoma.

Motoi F, Murakami Y, Okada KI, Matsumoto I, Uemura K, Satoi S, Sho M, Honda G, Fukumoto T, Yanagimoto H, Kinoshita S, Kurata M, Aoki S, Mizuma M, Yamaue H, Unno M; Multicenter Study Group of Pancreatobiliary Surgery (MSG-PBS).

World J Surg. 2019 Feb;43(2):634-641. doi: 10.1007/s00268-018-4814-4.

PMID:
30298281
17.

The Prognostic Significance of the Geriatric Nutritional Risk Index in Patients with Esophageal Squamous Cell Carcinoma.

Migita K, Matsumoto S, Wakatsuki K, Ito M, Kunishige T, Nakade H, Sho M.

Nutr Cancer. 2018 Nov-Dec;70(8):1237-1245. doi: 10.1080/01635581.2018.1512640. Epub 2018 Sep 20.

PMID:
30235009
18.

Risk Factors for Late-Onset Gastrointestinal Hemorrhage After Pancreatoduodenectomy for Pancreatic Cancer.

Nagai M, Sho M, Akahori T, Nishiwada S, Nakagawa K, Nakamura K, Tanaka T, Nishiofuku H, Kichikawa K, Ikeda N.

World J Surg. 2019 Feb;43(2):626-633. doi: 10.1007/s00268-018-4791-7.

PMID:
30225561
19.

A Novel Navigation for Laparoscopic Anatomic Liver Resection Using Indocyanine Green Fluorescence.

Nomi T, Hokuto D, Yoshikawa T, Matsuo Y, Sho M.

Ann Surg Oncol. 2018 Dec;25(13):3982. doi: 10.1245/s10434-018-6768-z. Epub 2018 Sep 14.

PMID:
30218249
20.

Prognostic factors for actual long-term survival in the era of multidisciplinary treatment for pancreatic ductal adenocarcinoma.

Nakagawa K, Akahori T, Nishiwada S, Nagai M, Nakamura K, Tanaka T, Tamamoto T, Ohbayashi C, Hasegawa M, Kichikawa K, Ikeda N, Sho M.

Langenbecks Arch Surg. 2018 Sep;403(6):693-700. doi: 10.1007/s00423-018-1709-7. Epub 2018 Sep 15.

PMID:
30218193
21.

A single-arm, phase II trial of neoadjuvant gemcitabine and S1 in patients with resectable and borderline resectable pancreatic adenocarcinoma: PREP-01 study.

Motoi F, Satoi S, Honda G, Wada K, Shinchi H, Matsumoto I, Sho M, Tsuchida A, Unno M; Study Group of Preoperative therapy for Pancreatic cancer (PREP).

J Gastroenterol. 2019 Feb;54(2):194-203. doi: 10.1007/s00535-018-1506-7. Epub 2018 Sep 4.

PMID:
30182219
22.

A neuroendocrine carcinoma with a well-differentiated adenocarcinoma component arising in Barrett's esophagus: a case report and literature review.

Doi S, Matsumoto S, Wakatsuki K, Migita K, Ito M, Kunishige T, Nakade H, Hatakeyama K, Ohbayashi C, Sho M.

Surg Case Rep. 2018 Aug 29;4(1):103. doi: 10.1186/s40792-018-0511-7.

23.

Predictive Factors for Delayed Gastric Emptying after Distal Gastrectomy with Roux-en-Y Reconstruction.

Matsumoto S, Wakatsuki K, Migita K, Ito M, Nakade H, Kunishige T, Kitano M, Nakatani M, Sho M.

Am Surg. 2018 Jun 1;84(6):1086-1090.

PMID:
29981653
24.

Anal gland adenocarcinoma in situ with pagetoid spread: a case report.

Ishioka K, Koyama F, Kuge H, Inoue T, Obara S, Nakamoto T, Sasaki Y, Nakamura Y, Takeda M, Ohbayashi C, Kuwahara M, Sho M.

Surg Case Rep. 2018 Jun 25;4(1):63. doi: 10.1186/s40792-018-0469-5.

25.

Clinical impact of developing better practices at the institutional level on surgical outcomes after distal pancreatectomy in 1515 patients: Domestic audit of the Japanese Society of Pancreatic Surgery.

Satoi S, Yamamoto T, Motoi F, Matsumoto I, Yoshitomi H, Amano R, Tahara M, Murakami Y, Arimitsu H, Hirono S, Sho M, Ryota H, Ohtsuka M, Unno M, Takeyama Y, Yamaue H.

Ann Gastroenterol Surg. 2018 Mar 25;2(3):212-219. doi: 10.1002/ags3.12066. eCollection 2018 May.

26.

LRRC15 Is a Novel Mesenchymal Protein and Stromal Target for Antibody-Drug Conjugates.

Purcell JW, Tanlimco SG, Hickson J, Fox M, Sho M, Durkin L, Uziel T, Powers R, Foster K, McGonigal T, Kumar S, Samayoa J, Zhang D, Palma JP, Mishra S, Hollenbaugh D, Gish K, Morgan-Lappe SE, Hsi ED, Chao DT.

Cancer Res. 2018 Jul 15;78(14):4059-4072. doi: 10.1158/0008-5472.CAN-18-0327. Epub 2018 May 15.

PMID:
29764866
27.

Von Willebrand Factor Aggravates Hepatic Ischemia-Reperfusion Injury by Promoting Neutrophil Recruitment in Mice.

Urisono Y, Sakata A, Matsui H, Kasuda S, Ono S, Yoshimoto K, Nishio K, Sho M, Akiyama M, Miyata T, Okuchi K, Nishimura S, Sugimoto M.

Thromb Haemost. 2018 Apr;118(4):700-708. doi: 10.1055/s-0038-1636529. Epub 2018 Apr 4.

PMID:
29618155
28.

Prognostic Significance of the Prognostic Nutritional Index in Patients with Recurrent Esophageal Squamous Cell Carcinoma.

Nakatani M, Migita K, Matsumoto S, Wakatsuki K, Ito M, Nakade H, Kunishige T, Kitano M, Sho M.

Nutr Cancer. 2018 Apr;70(3):467-473. doi: 10.1080/01635581.2018.1445771. Epub 2018 Mar 12.

PMID:
29528703
29.

K-ras mutation analysis of residual liquid-based cytology specimens from endoscopic ultrasound-guided fine needle aspiration improves cell block diagnosis of pancreatic ductal adenocarcinoma.

Sekita-Hatakeyama Y, Nishikawa T, Takeuchi M, Morita K, Takeda M, Hatakeyama K, Nakai T, Uchiyama T, Itami H, Fujii T, Mitoro A, Sho M, Ohbayashi C.

PLoS One. 2018 Mar 1;13(3):e0193692. doi: 10.1371/journal.pone.0193692. eCollection 2018.

30.

Significance of bacterial culturing of prophylactic drainage fluid in the early postoperative period after liver resection for predicting the development of surgical site infections.

Ishioka K, Hokuto D, Nomi T, Yasuda S, Yoshikawa T, Matsuo Y, Akahori T, Nishiwada S, Nakagawa K, Nagai M, Nakamura K, Ikeda N, Sho M.

Surg Today. 2018 Jun;48(6):625-631. doi: 10.1007/s00595-018-1629-8. Epub 2018 Jan 29.

PMID:
29380135
31.

Does anatomic resection improve the postoperative outcomes of solitary hepatocellular carcinomas located on the liver surface?

Hokuto D, Nomi T, Yasuda S, Yoshikawa T, Ishioka K, Yamada T, Takahiro A, Nakagawa K, Nagai M, Nakamura K, Kanehiro H, Sho M.

Surgery. 2018 Feb;163(2):285-290. doi: 10.1016/j.surg.2017.08.024. Epub 2017 Nov 28.

PMID:
29191676
32.

Is distal pancreatectomy with en-bloc celiac axis resection effective for patients with locally advanced pancreatic ductal adenocarcinoma? -Multicenter surgical group study.

Yamamoto T, Satoi S, Kawai M, Motoi F, Sho M, Uemura KI, Matsumoto I, Honda G, Okada KI, Akahori T, Toyama H, Kurata M, Yanagimoto H, Yamaue H, Unno M, Kon M, Murakami Y.

Pancreatology. 2018 Jan;18(1):106-113. doi: 10.1016/j.pan.2017.11.005. Epub 2017 Nov 14.

PMID:
29153701
33.

Reinforced staplers for distal pancreatectomy.

Kawai M, Hirono S, Okada KI, Satoi S, Yanagimoto H, Kon M, Murakami Y, Kondo N, Sho M, Akahori T, Toyama H, Fukumoto T, Fujii T, Matsumoto I, Eguchi H, Ikoma H, Takeda Y, Fujimoto J, Yamaue H.

Langenbecks Arch Surg. 2017 Dec;402(8):1197-1204. doi: 10.1007/s00423-017-1634-1. Epub 2017 Nov 4.

PMID:
29103084
34.

Enavatuzumab, a Humanized Anti-TWEAK Receptor Monoclonal Antibody, Exerts Antitumor Activity through Attracting and Activating Innate Immune Effector Cells.

Ye S, Fox MI, Belmar NA, Sho M, Chao DT, Choi D, Fang Y, Zhao V, Keller SF, Starling GC, Culp PA.

J Immunol Res. 2017;2017:5737159. doi: 10.1155/2017/5737159. Epub 2017 Sep 17.

35.

Risk Factors for Unresectable Recurrence After Up-Front Surgery for Colorectal Liver Metastasis.

Hokuto D, Nomi T, Yasuda S, Yoshikawa T, Ishioka K, Yamada T, Akahori T, Nakagawa K, Nagai M, Nakamura K, Obara S, Kanehiro H, Sho M.

World J Surg. 2018 Mar;42(3):884-891. doi: 10.1007/s00268-017-4195-0.

PMID:
28879511
36.

The prognostic significance of inflammation-based markers in patients with recurrent gastric cancer.

Migita K, Matsumoto S, Wakatsuki K, Ito M, Kunishige T, Nakade H, Kitano M, Nakatani M, Sho M.

Surg Today. 2018 Mar;48(3):282-291. doi: 10.1007/s00595-017-1582-y. Epub 2017 Aug 23.

PMID:
28836056
37.

Long-term observation and treatment of a widespread intraductal papillary neoplasm of the bile duct extending from the intrapancreatic bile duct to the bilateral intrahepatic bile duct: A case report.

Hokuto D, Nomi T, Yasuda S, Yoshikawa T, Ishioka K, Yamada T, Akahori T, Nakagawa K, Nagai M, Nakamura K, Obara S, Kanehiro H, Sho M.

Int J Surg Case Rep. 2017;38:166-171. doi: 10.1016/j.ijscr.2017.07.031. Epub 2017 Jul 23.

38.

Developing better practices at the institutional level leads to better outcomes after pancreaticoduodenectomy in 3,378 patients: domestic audit of the Japanese Society of Pancreatic Surgery.

Satoi S, Yamamoto T, Yoshitomi H, Motoi F, Kawai M, Fujii T, Wada K, Arimitsu H, Sho M, Matsumoto I, Hirano S, Yanagimoto H, Ohtsuka M, Unno M, Yamaue H, Kon M.

J Hepatobiliary Pancreat Sci. 2017 Sep;24(9):501-510. doi: 10.1002/jhbp.492. Epub 2017 Sep 7.

PMID:
28749593
39.

TS-1 (tegafur/gimeracil/oteracil)-induced systemic lupus erythematosus with skin lesions and anti-Sm antibody.

Miyagawa F, Sugano Y, Sho M, Asada H.

Eur J Dermatol. 2017 Dec 1;27(6):646-647. doi: 10.1684/ejd.2017.3101. No abstract available.

PMID:
28721931
40.

Effect of Neoadjuvant Nab-Paclitaxel plus Gemcitabine Therapy on Overall Survival in Patients with Borderline Resectable Pancreatic Cancer: A Prospective Multicenter Phase II Trial (NAC-GA Trial).

Okada KI, Shimokawa T, Hirono S, Kawai M, Sho M, Satoi S, Matsumoto I, Eguchi H, Murakami Y, Yamada S, Doi M, Yamaue H; NAC-GA investigators.

Oncology. 2017;93(5):343-346. doi: 10.1159/000478660. Epub 2017 Jul 19.

PMID:
28719890
41.

Usefulness of computed tomography density of a tumor in predicting the response of advanced esophageal cancer to preoperative chemotherapy.

Wakatsuki K, Matsumoto S, Migita K, Ito M, Kunishige T, Nakade H, Nakatani M, Kitano M, Takano M, Obayashi C, Sho M.

Surgery. 2017 Oct;162(4):823-835. doi: 10.1016/j.surg.2017.06.003. Epub 2017 Jul 11.

PMID:
28709645
42.

Retrospective Study of the Correlation Between Pathological Tumor Size and Survival After Curative Resection of T3 Pancreatic Adenocarcinoma: Proposal for Reclassification of the Tumor Extending Beyond the Pancreas Based on Tumor Size.

Kurata M, Honda G, Murakami Y, Uemura K, Satoi S, Motoi F, Sho M, Matsumoto I, Kawai M, Yanagimoto H, Fukumoto T, Nagai M, Gosho M, Unno M, Yamaue H; Multicenter Study Group of Pancreatobiliary Surgery (MSG-PBS).

World J Surg. 2017 Nov;41(11):2867-2875. doi: 10.1007/s00268-017-4077-5.

43.

Preoperative Plasma Fibrinogen is Associated with Lymph Node Metastasis and Predicts Prognosis in Resectable Esophageal Cancer.

Wakatsuki K, Matsumoto S, Migita K, Ito M, Kunishige T, Nakade H, Nakatani M, Kitano M, Sho M.

World J Surg. 2017 Aug;41(8):2068-2077. doi: 10.1007/s00268-017-3991-x.

PMID:
28321554
44.

Multicenter, randomized, open-label Phase II study comparing S-1 alternate-day oral therapy with the standard daily regimen as a first-line treatment in patients with unresectable advanced pancreatic cancer.

Yamaue H, Shimizu A, Hagiwara Y, Sho M, Yanagimoto H, Nakamori S, Ueno H, Ishii H, Kitano M, Sugimori K, Maguchi H, Ohkawa S, Imaoka H, Hashimoto D, Ueda K, Nebiki H, Nagakawa T, Isayama H, Yokota I, Ohashi Y, Shirasaka T.

Cancer Chemother Pharmacol. 2017 Apr;79(4):813-823. doi: 10.1007/s00280-017-3250-8. Epub 2017 Mar 1.

PMID:
28251282
45.

[Huge Hepatocellular Carcinoma with Portal Vein and Inferior Vena Cava Thrombi Treated with Curative Liver Resection and Perioperative Hepatic Arterial Infusion Chemotherapy - A Case Report].

Obara S, Nomi T, Yamato I, Hokuto D, Yasuda S, Kawaguchi C, Yoshikawa T, Sho M, Yamada T, Akahori T, Kinoshita S, Nagai M, Kanehiro H, Nakajima Y.

Gan To Kagaku Ryoho. 2016 Nov;43(12):1779-1781. Japanese.

PMID:
28133129
46.

[A Case of Advanced Hepatocellular Carcinoma, Its Disease Progression Could Be Controlled by Multimodal Treatment].

Yoshikawa T, Nomi T, Hokuto D, Yamato I, Yasuda S, Obara S, Kawaguchi C, Kinoshita S, Nishiwada S, Nagai M, Akahori T, Yamada T, Sho M, Kanehiro H, Nakajima Y.

Gan To Kagaku Ryoho. 2016 Nov;43(12):1754-1756. Japanese.

PMID:
28133121
47.

Intraarterial Therapy Using Micellar Nanoparticles Incorporating SN-38 in a Rabbit Liver Tumor Model.

Nishiofuku H, Tanaka T, Fukuoka Y, Sato T, Masada T, Tatsumoto S, Sho M, Yamato I, Yasuda S, Matsushima S, Takano M, Ohbayashi C, Kichikawa K.

J Vasc Interv Radiol. 2017 Mar;28(3):457-464. doi: 10.1016/j.jvir.2016.10.032. Epub 2016 Dec 29.

PMID:
28041782
48.

Pharmacokinetics and Histopathological Findings of Chemoembolization Using Cisplatin Powder Mixed with Degradable Starch Microspheres in a Rabbit Liver Tumor Model.

Sato T, Tanaka T, Nishiofuku H, Fukuoka Y, Sakaguchi H, Masada T, Tatsumoto S, Marugami N, Takano M, Yamato I, Sho M, Ohbayashi C, Hirai T, Kichikawa K.

Cardiovasc Intervent Radiol. 2017 Mar;40(3):438-444. doi: 10.1007/s00270-016-1512-1. Epub 2016 Nov 21.

PMID:
27872985
49.

Proposed Nomogram Predicting the Individual Risk of Malignancy in the Patients With Branch Duct Type Intraductal Papillary Mucinous Neoplasms of the Pancreas.

Jang JY, Park T, Lee S, Kim Y, Lee SY, Kim SW, Kim SC, Song KB, Yamamoto M, Hatori T, Hirono S, Satoi S, Fujii T, Hirano S, Hashimoto Y, Shimizu Y, Choi DW, Choi SH, Heo JS, Motoi F, Matsumoto I, Lee WJ, Kang CM, Han HS, Yoon YS, Sho M, Nagano H, Honda G, Kim SG, Yu HC, Chung JC, Nagakawa Y, Seo HI, Yamaue H.

Ann Surg. 2017 Dec;266(6):1062-1068. doi: 10.1097/SLA.0000000000001985.

PMID:
27607098
50.

Pseudosarcomatous myofibroblastic proliferation of the gallbladder mimicking early carcinoma.

Sho M, Hatakeyama K, Obara S, Kunishige T, Takano M, Kasai T, Ohbayashi C, Nakajima Y.

Pathol Int. 2016 Aug;66(8):478-80. doi: 10.1111/pin.12430. Epub 2016 Jun 28. No abstract available.

PMID:
27349494

Supplemental Content

Support Center